President Trump crashed a Mother’s Day “celebration” alongside former Fox News host Jeanine Pirro and Defense Secretary Pete Hegseth during this week’s “Saturday Night Live” cold open.

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

All products featured on Bon Appétit are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links.

The Department of Health and Human Services has granted an exemption to the Centers for Disease Control and Prevention to hire a new class of its disease detectives, multiple CDC officials said ...

As DNA testing continued to improve, the Indiana State Police's Cold Case Team continued to work on the case, authorities said, and in 2024 they developed a "much stronger DNA profile," again from ...

The Bard build in Oblivion Remastered offers a unique playstyle, blending stealth, magic, and social skills. It emphasizes intelligence, personality, and agility, making Bretons an ideal race.

The coffee chain is launching a "light and silky" Brown Sugar Cream Cold Foam Starbucks Starbucks is offering free cold foam with its cold drinks from May 7 to May 11 The coffee chain is also ...

These cold lunch ideas are perfect for bringing to the office to enjoy during your lunch break. Ready in just 20 minutes or less, these lunches will keep you cool and satisfied for the remainder ...

safety and initial efficacy of enteric-coated tablets of ANX1502 in up to seven patients with cold agglutinin disease (CAD). Next Milestone: POC trial completion in up to seven CAD patients ...

The Luka Doncic trade was not a standalone instance of Mavericks general manager Nico Harrison betraying those in the organization. According to ESPN’s Tim MacMahon and a long list of Mavericks ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...